Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ45530 Inhibitors

FLJ45530 inhibitors are a class of small molecules that specifically target the FLJ45530 protein, a gene product associated with various cellular processes, including signaling pathways, gene expression, and cellular proliferation. These inhibitors are designed to modulate the activity of FLJ45530 by binding to critical sites on the protein, altering its conformation or functionality. By inhibiting the activity of FLJ45530, these compounds can disrupt downstream signaling cascades and biological processes that rely on this protein's proper function. This makes them valuable tools for investigating the biological roles of FLJ45530 in cellular and molecular research. These inhibitors are often employed in experiments to study protein interactions, post-translational modifications, and other biochemical events that are regulated by FLJ45530 in vitro and in cell-based systems.

Chemically, FLJ45530 inhibitors typically feature diverse structural scaffolds that allow for selective binding to specific domains of the FLJ45530 protein. These scaffolds often include heterocyclic cores, aromatic rings, and functional groups that engage in hydrogen bonding, van der Waals forces, or hydrophobic interactions with the protein. Structural optimization of these inhibitors is frequently performed to enhance their binding affinity, selectivity, and overall stability in biological systems. Researchers utilize these compounds to better understand the structural and functional characteristics of FLJ45530, as well as its broader role in various cellular contexts. Through the use of such inhibitors, scientists can dissect complex molecular pathways and gather detailed insights into how FLJ45530 contributes to critical cellular mechanisms.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent kinase inhibitor that can non-selectively inhibit protein kinases possibly related to FLJ45530.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Inhibits DNA methyltransferases, potentially affecting gene expression of proteins including FLJ45530.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Histone deacetylase inhibitor, altering chromatin structure and possibly gene expression of FLJ45530.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor that can stabilize proteins and possibly alter degradation pathways involving FLJ45530.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

HSP90 inhibitor that can disrupt protein folding and may affect FLJ45530 client proteins.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Tyrosine kinase inhibitor that may affect signaling pathways in which FLJ45530 is involved.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibits MEK and may alter the MAPK/ERK pathway, potentially affecting FLJ45530's role within this pathway.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$148.00
$597.00
75
(4)

Rac1 inhibitor that can alter actin cytoskeleton organization, potentially impacting FLJ45530's associated processes.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

Inhibits the Hedgehog signaling pathway, which may intersect with signaling pathways involving FLJ45530.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$65.00
$210.00
26
(2)

Glucose analog that inhibits glycolysis and can alter energy metabolism possibly related to FLJ45530.